G40.42
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
Clinical Classification Guidelines
Use Additional Code
- code, if known, to identify associated manifestations, such as:
- cortical blindness (H47.61-)
- global developmental delay (F88)
Inclusion Terms
- CDKL5
Medical Intelligence & Overview
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder, also known as CDKL5 deficiency disorder, is a rare genetic condition that primarily affects brain development. It is characterized by seizures, early-onset developmental delays, and intellectual disabilities. This disorder is classified under the ICD-10 code G40.42 and is associated with mutations in the CDKL5 gene, which plays a critical role in brain development and function. Individuals with this condition often experience severe neurological and motor challenges, requiring comprehensive medical and supportive care throughout their lives.
Causes & Symptoms
Clinical Causes: This disorder is caused by mutations or alterations in the CDKL5 gene. These genetic changes can occur spontaneously (de novo) or be inherited from a parent. The CDKL5 gene provides instructions for making a protein that is vital for normal brain development, particularly in areas related to learning, memory, and movement. When this gene is disrupted, it leads to the development of CDKL5 deficiency disorder. The mutations can result from various genetic variations, including point mutations, deletions, or duplications affecting the gene's structure and function.
Key Symptoms: Seizures that often begin within the first months of life, including atypical or epileptic seizures Global developmental delays affecting motor skills, speech, and cognition Intellectual disability and learning difficulties Low muscle tone (hypotonia) in infancy Loss of motor skills previously acquired Breathing irregularities and apneas Sensory sensitivities, such as sensitivity to light, sound, or touch Gastrointestinal issues like feeding difficulties or reflux Sleep disturbances and irritability Autistic-like behaviors, including repetitive movements and social withdrawal Abnormalities in eye movements and vision problems
Diagnostic & Treatment
Diagnosis Path: Diagnosis of CDKL5 deficiency disorder involves a combination of clinical assessments and genetic testing. Healthcare professionals typically perform an extensive neurological evaluation to observe seizure patterns and developmental milestones. A definitive diagnosis is often confirmed through genetic analysis, such as next-generation sequencing or targeted gene testing, which identifies mutations in the CDKL5 gene. Additional tests like brain MRI might be performed to assess structural brain abnormalities, although these are not specific for the disorder.
Treatment Protocols: Anti-seizure medications to control seizures, though responses can be variable Physical, occupational, and speech therapies to support motor skills, communication, and daily functioning Behavioral interventions to address autistic-like behaviors and sensory sensitivities Nutritional support and intervention for feeding difficulties Regular monitoring and management of associated medical issues, such as breathing irregularities Family support and counseling to assist with the emotional and practical aspects of caring for an individual with CDKL5 deficiency
Clinical Advice & FAQs
Billing Guidance
Is G40.42 a billable ICD-10 code?
Yes, G40.42 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G40.42?
Clinical documentation must specify the nature of Cyclin-Dependent Kinase-Like 5 Deficiency Disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference